Monetary and fiscal policies to play key role in reviving financial sector: Rohit Agarwal

Monetary and fiscal policies to play key role in reviving financial sector: Rohit Agarwal

“We cannot have an economy where credit growth slows down to 10-11% and the economy grows at 6.5-7%. But if you just look at what is starting to happen is there was a deficit of liquidity of about three lakh crores and just recently we seem to see that there are signs of the central … Read more

Vijay Kedia warns retail investors to be cautious of frothy market

Vijay Kedia warns retail investors to be cautious of frothy market

“Today also I am feeling the same thing that there is a froth in this market, there is a froth in SME, there is a froth in IPO and of course many stocks. The retailer investors, as you say are innocent people, so they should be careful,” says Vijay Kedia, MD, Kedia Securities.What is your … Read more

Valuation concerns ebbed? 400 smallcaps give double-digit weekly returns of upto 52%

Valuation concerns ebbed? 400 smallcaps give double-digit weekly returns of upto 52%

MUMBAI – Concerns over high valuations in the smallcap universe seems to have ebbed as stocks rallied in the week gone by and outperformed benchmarks by a wide margin. As many as 400 smallcap stocks gave double-digit returns of upto 52% in the week ended April 5, data by Ace Equity showed. Of these 400 … Read more

Ashwini Agarwal on why Buffett Indicator of market cap to GDP may not apply to India

Ashwini Agarwal on why Buffett Indicator of market cap to GDP may not apply to India

Ashwini Agarwal, Founder, Demeter Advisors, says the market is kind of ignoring the elections which is always a very dangerous thing to do. You may be right that the market is kind of discounting a good outcome for the BJP and that may or may not happen. So, yes, that is an issue. But, having … Read more

Blue Jet Healthcare IPO, 4 other SME issues to hit the market next week, aiming to raise nearly Rs 1,000 cr

Blue Jet Healthcare IPO, 4 other SME issues to hit the market next week, aiming to raise nearly Rs 1,000 cr

One mainboard IPO of Blue Jet Healthcare and four other SME issues will open for public subscription next week, aiming to raise a cumulative of Rs 938 crore. In the previous week, IRM Energy came up with its public offer to raise around Rs 545 crore. Analysts say they expect a flurry of IPOs in … Read more

MSMEs’ revenues to touch pre-COVID levels: Report

MSMEs’ revenues to touch pre-COVID levels: Report

Nearly all the MSMEs in the country this fiscal would be surpassing the revenues they achieved in the pre-covid level, but their operating profits may be well below the 2019 levels as they are not able to pass on the commodity price increases, said ratings firm Crisil. Almost all the MSMEs are expected to cross … Read more

MSMEs’ revenues to touch pre-COVID levels: Report

MSMEs’ revenues to touch pre-COVID levels: Report

Nearly all the MSMEs in the country this fiscal would be surpassing the revenues they achieved in the pre-covid level, but their operating profits may be well below the 2019 levels as they are not able to pass on the commodity price increases, said ratings firm Crisil. Almost all the MSMEs are expected to cross … Read more

Gradual shift from informal to formal for MSMEs

Gradual shift from informal to formal for MSMEs

There is a huge corpus of work emphasizing the importance of formalization and the persistence of informality in the economy. Representing a major feature of labour markets worldwide, the informal sector consists of activities operating outside the regulatory framework that would potentially add value to tax revenue and the GDP but go unaccounted. A recent … Read more

Bulk drugs SMEs raise concern about Central Government giving only 11% share to MSMEs in second PLI scheme

Bulk drugs SMEs raise concern about Central Government giving only 11% share to MSMEs in second PLI scheme

The budget allocated to SMEs also is very miniscule with only Rs 1600 Crore in the PLI-I scheme Domestic pharmaceutical Small And Medium Enterprises (SMEs) which manufacture bulk drugs or Active Pharmaceutical Ingredients (APIs) have raised concern that Central Government has given more than 71% share to top few companies and only 11% share to … Read more